Clik here to view.
Clik here to view.
Clik here to view.
セル・セラピー・カタパルトがセルバンクへ向けてノーベル賞受賞の知的財産権のライセンスを受ける
ロンドン & 京都 （ビジネスワイヤ） — 英国の細胞療法産業の発展に傾注して同国の健康と富の増進を図るセル・セラピー・カタパルトは、iPSアカデミアジャパンと特許ライセンス契約を締結しました。この契約はGMPレベルの人工多能性幹細胞（iPS細胞）バンクを英国に設立する上で、非常に重要な前進となります。...
View ArticleClik here to view.
世界最大級のナノテクノロジー総合展“nano tech 2015” 開催！
東京 （ビジネスワイヤ） — nano tech 実行委員会（委員長：大阪大学 川合 知二 教授）は、2015年1月28日から30日の3 日間、東京ビッグサイトにてnano tech 2015 第14...
View ArticleClik here to view.
PharmaEngine Announces Phase 2 PEPCOL Study Presented at the 2015 ASCO GI of...
TAIPEI, Taiwan PharmaEngine, Inc. (TWO:4162) today announced that the data from the randomized non-comparative phase 2 PEPCOL study of PEP02 (MM-398, liposome irinotecan injection) in unresectable...
View ArticleClik here to view.
Not for the Faint of CAR-T: The CAR-T Therapy Landscape in 2015
LONDON & BOSTON & TOKYO The market interest surrounding anti-tumour CAR-T therapies was one of the defining themes of 2014 and investor enthusiasm for the area is unlikely to abate in 2015....
View ArticleClik here to view.
珀金埃尔默在中国苏州新设的医学检验所开业
马萨诸塞州沃尔瑟姆和中国苏州 (美国商业资讯) — PerkinElmer, Inc.是一家专注于改善人类及环境健康和安全的全球领先公司，该公司今天宣布，苏州珀金埃尔默医学检验所有限公司在中国开业。 最近，超过130位当地官员、关键意见领袖、医学研究专业人员和学术界人士参加了该检验所的开业仪式。该新设施为中国医院和患者提供全方位的检验服务，支持新生儿出生缺陷和成人感染性疾病的预防。...
View ArticleClik here to view.
世界最大級のナノテクノロジー総合展“nano tech 2015” 開催！
東京 （ビジネスワイヤ） — nano tech 実行委員会（委員長：大阪大学 川合 知二 教授）は、2015年1月28日から30日の3 日間、東京ビッグサイトにてnano tech 2015 第14...
View ArticleClik here to view.
CBI Pharma to Hold 6th Annual IVD Summit 2015 on March 12-13 in Shenzhen, China
SHANGHAI CBI Pharma, a subsidiary of ENMORE, will hold the 6th Annual IVD Summit 2015 (IVDS 2015) in Shenzhen, China on March 12-13, 2015. As the No.1 IVD industry summit in China, IVDS discusses...
View ArticleClik here to view.
PreAnalytiX GmbH, NuGEN Technologies and RUCDR Infinite Biologics Partner to...
HOMBRECHTIKON, Switzerland & SAN CARLOS, Calif. & PISCATAWAY, N.J. PreAnalytiX GmbH, NuGEN Technologies, Inc. and RUCDR Infinite Biologics (RUCDR), today announced a joint project to...
View ArticleClik here to view.
SuperSonic Imagine Has Signed the Exclusive Distribution Agreement with...
AIX-EN-PROVENCE, France SuperSonic Imagine (Euronext : SSI, FR0010526814), a company specializing in ultrasound medical imaging equipment, announces the signing of an exclusive partnership with...
View ArticleClik here to view.
Promega PowerPlex® Fusion 6C System Improves Mixture Interpretation with...
MADISON, Wis. Promega Corporation announces the release of the PowerPlex® Fusion 6C System, a 6-color, 27-locus multiplex. The system combines common and informative loci to overcome typical...
View ArticleClik here to view.
Hoya Announces Third Quarter Financial Results
TOKYO Hoya Corporation (TOKYO:7741) today announced financial results for the third quarter ended December 31, 2014. During the quarter, revenues increased 16.9% to 128,206 million yen, and profit...
View ArticleClik here to view.
Dr. Jeremy Levin & Prof. (Dr.) Vijay Kuchroo Join Biocon’s Board of Directors
BANGALORE, India Biocon Ltd, an emerging global biopharmaceutical enterprise and India’s largest fully-integrated biotech company, has expanded its Board of Directors with the induction of two...
View ArticleClik here to view.
pSivida Corp. Announces Second Quarter Fiscal Year 2015 Financial Results...
WATERTOWN, Mass. pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that its financial results...
View ArticleClik here to view.
WaVe Life Sciences Closes $18 Million Series A Financing to Advance...
BOSTON & OKINAWA, Japan WaVe Life Sciences today announced that it closed an $18 million Series A financing, led by RA Capital Management, LLC and Kagoshima Shinsangyo Sosei Investment LP,...
View ArticleClik here to view.
Life Sciences Hiring Index Posts Slight Decline to End Record Year
WEST ORANGE, N.J. ZRG Partners, Inc. has announced the final findings for 2014 with their fourth quarter Global Life Sciences Hiring Index. Despite a small drop from Q3, 2014 ended with the highest...
View ArticleClik here to view.
Acucela Received a Request to Hold a Special Meeting of Shareholders
SEATTLE Acucela Inc. (TOKYO: 4589), a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening...
View ArticleClik here to view.
ENMORE: Immunotherapy Industry Summit 2015 — Cellular Immunotherapy Focus
SHANGHAI With the development of clinical translation, the immunotherapy industry, especially the cellular immunotherapy, is gaining popularity as an emerging biotherapy method. On April 10-11,...
View ArticleClik here to view.
THERAVECTYS Obtains Orphan Drug Designation from the European Medicines...
PARIS “On World Cancer Day 2015, we are proud to be one of the most innovative players in the immuno-oncology space, developing a new kind of treatment for more sustainable remission. In our...
View Article